At Day 1.5, peak IFN-γ production altered the cytokine and chemokine profiles in the tumor microenvironment, collaborating with IFN-γ/pSTAT1 signaling to induce tumor suppression following ACT 31. This evidence concerns the gene IFNG and neoplasm.